HK12295A - Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained - Google Patents

Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained

Info

Publication number
HK12295A
HK12295A HK12295A HK12295A HK12295A HK 12295 A HK12295 A HK 12295A HK 12295 A HK12295 A HK 12295A HK 12295 A HK12295 A HK 12295A HK 12295 A HK12295 A HK 12295A
Authority
HK
Hong Kong
Prior art keywords
isosorbide
formulations
stabilized
preparation
mononitrate
Prior art date
Application number
HK12295A
Other languages
English (en)
Inventor
Massimo Calanchi
Piergiorgio Rossi
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Publication of HK12295A publication Critical patent/HK12295A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK12295A 1985-10-15 1995-01-26 Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained HK12295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22493/85A IT1187750B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute

Publications (1)

Publication Number Publication Date
HK12295A true HK12295A (en) 1995-02-03

Family

ID=11197007

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12295A HK12295A (en) 1985-10-15 1995-01-26 Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained

Country Status (12)

Country Link
US (1) US4812316A (xx)
EP (1) EP0219161B1 (xx)
JP (1) JPS62123114A (xx)
AT (1) ATE71290T1 (xx)
AU (1) AU591185B2 (xx)
CA (1) CA1285489C (xx)
DE (1) DE3683342D1 (xx)
ES (1) ES2035819T3 (xx)
GR (1) GR3004285T3 (xx)
HK (1) HK12295A (xx)
IT (1) IT1187750B (xx)
ZA (1) ZA867768B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111068644A (zh) * 2019-12-20 2020-04-28 中海油天津化工研究设计院有限公司 一种均四甲苯氧化制均酐催化剂及其制备方法

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64726B1 (en) * 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
IT1237638B (it) * 1989-10-25 1993-06-12 Ghirardi Paolo E. Impiego dell'isosorbide 2-mononitrato per la preparazione di composi- zioni farmaceutiche atte al trattamento dell'angina pectoris
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE4313726A1 (de) * 1993-04-27 1994-11-03 Byk Nederland Bv Feste Darreichungsform
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
WO1998005306A1 (en) * 1996-08-02 1998-02-12 Cal International Limited Controlled release tablet formulation of isosorbide-5-mononitrate
US5851555A (en) * 1997-08-15 1998-12-22 Fuisz Technologies Ltd. Controlled release dosage forms containing water soluble drugs
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
JP4696210B2 (ja) * 2000-06-07 2011-06-08 トーアエイヨー株式会社 イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
JP4840549B2 (ja) * 2000-11-20 2011-12-21 トーアエイヨー株式会社 安定な血管拡張剤及びその製造方法
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
AU2006340298B2 (en) * 2006-03-16 2012-10-04 Glycologic Limited Gastric raft composition comprising preferably processed starches for inducing satiety
CN115487162B (zh) * 2022-10-13 2023-10-13 山东力诺制药有限公司 一种单硝酸异山梨酯缓释片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2301664C3 (de) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3325652A1 (de) * 1983-07-15 1985-01-24 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste, stabile isosorbid-5-mononitrat enthaltende arzneimittelzubereitungen und verfahren zu ihrer herstellung
JPS60181052A (ja) * 1984-02-29 1985-09-14 Tooa Eiyoo Kk 安定なイソソルビド硝酸エステル組成物及びその製造法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111068644A (zh) * 2019-12-20 2020-04-28 中海油天津化工研究设计院有限公司 一种均四甲苯氧化制均酐催化剂及其制备方法
CN111068644B (zh) * 2019-12-20 2023-01-03 中海油天津化工研究设计院有限公司 一种均四甲苯氧化制均酐催化剂及其制备方法

Also Published As

Publication number Publication date
JPH0524888B2 (xx) 1993-04-09
JPS62123114A (ja) 1987-06-04
ATE71290T1 (de) 1992-01-15
AU591185B2 (en) 1989-11-30
DE3683342D1 (de) 1992-02-20
ES2035819T3 (es) 1993-05-01
ZA867768B (en) 1987-06-24
CA1285489C (en) 1991-07-02
IT8522493A0 (it) 1985-10-15
IT1187750B (it) 1987-12-23
GR3004285T3 (xx) 1993-03-31
EP0219161B1 (en) 1992-01-08
EP0219161A3 (en) 1988-01-13
EP0219161A2 (en) 1987-04-22
AU6383186A (en) 1987-04-16
US4812316A (en) 1989-03-14

Similar Documents

Publication Publication Date Title
EP0219161A3 (en) Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
ATE106239T1 (de) Zubereitungen mit kontrollierter wirkstoffabgabe.
JO1552B1 (en) New pyridizinamine derivatives
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
IL53535A (en) Stabilized folic acid, its preparation and animal feed materals comprising it
JPS53109555A (en) Preparation of modified keratin-containing material
IL57847A0 (en) Adducts of k vitaminic compounds and stabilizing vitamins,preparation thereof and stabilized adducts thus provided
HUT44909A (en) Herbicides comprising 1-aryl-4-substituted-1,4-dihydro-5h-tetrazol-5-one derivatives and their sulphur analogs as active ingredient and process for producing the active ingredients and intermediaries thereof
JPS53127841A (en) W/o-type lipstick
IL86970A0 (en) Ascorbic acid derivative,its preparation and its use as antioxidant
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
OA09495A (en) Novel use of vitamin d compounds to inhibit replication of the aids virus
PT83456A (en) Process for the preparation of pharmaceutical compositions with controlled release of active substance
DE3660806D1 (en) Novel compound, its production and insecticidal and acaricidal composition containing it as an active ingredient
JPS5334752A (en) Preparation of gamma-ionones and their derivatives
JPS5283413A (en) Preparation of 3,3-dimethyl-4-pentenoic acid or its esters
JPS5391188A (en) Preparation of glycyl lysine
JPS5386086A (en) Preparation of insoluble gluco amylase
JPS5283421A (en) Preparation of phenoxypropylamine derivatives
DE3563416D1 (en) Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
JPS523890A (en) Preparation of stabilized enzymes by micro capsulation
JPS5277078A (en) Preparation of 7-aminocephalosporanic acid derivative
IL49157A0 (en) Novel esters and ester-amides of(di)thiolphosphoric and thiolphosphonic acids and their thionoanalogues,their preparation and their use as pesticides
JPS5423194A (en) Preparation of inosine-5'-monophosphate

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)